Maverick Ventures — 2014 Investments
2 investments dated 2014 · listed companies and verified rows first · show all
Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions.
BiotechHealthtechSan Francisco, US
Thomas B. Neff(Executive Officer, Director)Frank H. Valone(Executive Officer)inK. Peony Yu(Executive Officer)inPat Cotroneo(Executive Officer)inRory Riggs(Founder)
BoardRory B. Riggs(Director)
Co-investorsAvalon BioVenturesForesite CapitalRidgeback CapitalScientia Ventures
TrueVault provides a SaaS platform that helps businesses achieve privacy compliance with regulations like GDPR and CCPA through data mapping, customer notices, and internal policy guidance.
Enterprise SoftwareLegalTechSaaSSan Francisco, US
Jason Wang(Founder)inJustin Gold(Fractional CRO)Andrew MitchellNic Villasenor(Vice President, Ops)Jeremy Villasenor(Staff Engineer)Travis Crist(Head of Engineering)
Co-investorsACTAI VenturesFundersClubK5 VenturesLaunchpad LAPioneerY Combinator+15 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







